Program Information

This Weitzman ECHO Series for Ohio connects primary care providers, behavioral health providers, and other care team members to a community of peers and subject-matter experts from across Ohio to address high-value psychiatric topics. The multidisciplinary faculty team will offer best practices for screening, assessing, and managing psychiatric conditions through a trauma-informed lens.

Weitzman ECHO Substance Use Disorders is a no-cost, 9-month, 18-session continuing education series that begins on Friday, May 17th, 2024 and is offered in collaboration with Buckeye Health Plan and Ohio University. Each one-hour ECHO session consists of a brief didactic presentation on key topics related to adult psychiatry, followed by patient case discussions, submitted by participating providers.

CME, CNE, CPE, and CEU credits will be provided for physicians, nurse practitioners, physician assistants, pharmacists, and social workers, among others, by Community Health Center, Inc., an accredited provider through Joint Accreditation for Interprofessional Continuing Education.

This activity meets the first and third Friday of every month from  of every month from 12-1pm ET.

Acknowledgement of Support

This program is supported by Ohio’s Medicaid Managed Care Plans' community reinvestment initiatives through the 2023 Collaborative Medicaid Managed Care Community Reinvestment Fund. This fund is administered by the Ohio Association of Health Plans. 

Target Audience

This activity is appropriate for the following audiences:

• Primary care providers (MD, DO, NP, PA)
• Behavioral health providers
• Other members of the care team

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

• Enhance collaboration between primary care and behavioral health providers to improve medication management and transitions of care.
• Utilize patient-centered and trauma-informed techniques to understand patient risk factors and trends. 
• Illustrate best practices in the screening and assessment of patients experiencing common psychiatric conditions.
• Optimize the care of common co-occurring psychiatric conditions and medical comorbidities.
• Demonstrate evidence-based treatment approaches including psychopharmacology and behavioral techniques. 
• Implement methodologies to enhance patient adherence and shared decision-making.